|
We value Dunkle et al.’s1 critique of our published call for the South African Society of Psychiatrists (SASOP) to review their position on the care of ‘transgender and non-binary youth’.2 Ongoing dialogue is crucial for safeguarding the best interests of South African children. Public trust in the medical profession is enhanced when criticism is addressed constructively.
Our original publication criticised SASOP for framing all children with gender dysphoria as being transgender, not following best practice in developing their statement, ignoring systematic reviews highlighting weak evidence for gender-affirming care (GAC), relying on circular references, overlooking alternatives to GAC, overlooking the harms of GAC, and omitting the limitations of informed consent for irreversible procedures in children.2 Dunkle et al.’s rebuttal does not adequately address these points but instead introduces new discussion points, including critiques of the Cass Review, global consensus arguments and the African context. We will briefly respond to each of these.
Criticism of The Cass Review
The claim that our argument centres on the Cass Review’s policy recommendations for the UK is misleading. To clarify, our focus is on the global evidence base, which includes multiple systematic reviews,3,4,5,6,7,8,9 which is inadequate to support GAC for children – including in South Africa. Engagement with this evidence should be a prerequisite when developing a credible position statement on the care of transgender and non-binary youth.
The assertion that the Cass Review omitted affirming outcome data is incorrect. It evaluated 103 non-randomised observational studies using the Newcastle–Ottawa Scale; only two were of high quality, and 58% met sufficient standards for inclusion in the Cass Review analysis.10,11
Criticisms about its lack of accountability or transparency are unsubstantiated. Cheung et al.12 argue these critiques misrepresent both the process and the standards typical of United Kingdom (UK) independent reviews which are meant to minimise bias and conflict of interest, including that UK independent reviews are typically conducted by ‘a respected public figure with no ties to the area under review’.11,12 Kingdon et al.,13 McDeavitt et al.14 and Clayton et al.15 have responded to the common criticisms of the Cass Review, and have more than adequately defended its methodology. Engagement should focus on actual evidence, not advocacy group citations such as the Southern Poverty Law Center.16
Dunkle et al. state that most transgender youth benefit from access to GAC: ‘[the]overwhelming majority of transgender youth … benefit from access to care, or experience harm and distress when care is denied or made inaccessible’; but systematic reviews3,4,5,6,7,8,9 find no compelling evidence supporting this claim and consistently highlight the paucity of data on long-term outcomes. When a study purporting to prove evidence for the benefit of GAC is rated in a systematic review as being of low or very low certainty, then the true effect may be substantially different from the estimate of the effect or is likely to be substantially different from the estimate of the effect.17
Regarding the evidence base for an approach that focuses on psychological and social support rather than medicalisation – a thorough consideration of ethical principles recognises that when two approaches are associated with similar certainty of evidence, but one carries a lower risk of harm, a strong recommendation is supported in favour of the safer option.11,18
Appeal to global ‘consensus’
Kazlowska et al. outline GAC treatment models ranging from rights-based to evidence-based approaches.19 We propose that consensus-based approaches are a third category. A claim to consensus by Dunkle et al., without strong evidence, risks repeating past medical system failures, such as frontal lobotomies, the thalidomide tragedy and the opioid crisis.
Dunkle et al. cite guidelines from French, German, Austrian and Swiss medical societies20,21 which, rather than being evidence-based, reflect consensus among clinicians with vested interests, including providing GAC to children, and who consequently have much to lose in an objective consideration of the evidence. WPATH, also consensus-driven, has been criticised for poor guideline quality,22 disregarding its own reviews and bowing to political interference.11 These are the sources underpinning the SASOP position statement.
Kulatunga-Moruzi et al.11 discuss how many countries have adopted an evidence-based approach including Finland,23 Sweden,24 the UK,25 Norway,26 Italy,27 the US28 and New Zealand.29 We suggest that SASOP do the same.
African context
Contrary to claims about traditional African perspectives, child and adolescent GAC originates in and is largely driven by actors in the Global North, having emerged out of the Dutch protocol. Dunkle et al.’s references used in support of GAC are predominantly from the Global North,16,20,21,30 and GAC now represents a multi-billion-dollar industry, based on WPATH guidelines.31
Conclusion
Dunkle et al. have not substantively addressed our critique of the SASOP position statement. Their new discussion points regarding evidence, consensus, and the African context sidestep valid critique. The authors do not produce robust evidence that convincingly shows GAC interventions to be safe, effective, and in children’s best interests.
Additional issues for SASOP to consider include the temporary nature of gender distress in many children and adolescents,32 the impact of social transition on concretising cross-gender identification,33 insights from desistance and detransition research,34 the role of psychiatric comorbidities,35 changes in demographics, particularly the increase in gender dysphoria in adolescent girls,33 and how the risks of puberty blockers and hormone therapies have been minimised.11
Clinicians entrusted with caring for children need to confront challenges and uncertainties objectively, using robust evidence. As doctors, we do not want to believe that we may be harming children, and this cognitive dissonance may evoke denial and rationalisation to avoid shame. It takes courage to admit that we may need to reconsider strongly held views and positions. This is our challenge to South African medical colleagues.
Acknowledgements
Competing interests
The authors declare that they are official members of First Do No Harm Southern Africa. They have disclosed this affiliation fully and confirm that it has not influenced the design, conduct, or reporting of the research presented in this article. The authors declare that they have no personal or financial relationships that may have inappropriately influenced them in writing this article.
CRediT authorship contribution
Allan Donkin: Conceptualisation, Project administration Writing original draft, Writing review & editing. Reitze Rodseth: Conceptualisation, Project administration Writing original draft, Writing review & editing. Janet Giddy: Conceptualisation, Project administration Writing original draft, Writing review & editing. All authors reviewed the article, contributed to the discussion of results, approved the final version for submission and publication, and take respon sibility for the in tegrity of its findings.
Funding information
This research received no specific grant from any funding agency in the public, commercial or not for profit sectors.
Data availability
Data sharing is not applicable to this article as no new data were created or analysed in this study.
Disclaimer
The views and opinions expressed in this article are those of the authors and are the product of professional research. They do not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article s results, findings and content.
References
- Dunkle KL, Lynch I, Msweli S, et al. Locally relevant, ethically urgent: Defending SASOP’s stance on transgender and non-binary youth. S Afr J Psychiat. 2026;32(0), a2543. https://doi.org/10.4102/sajpsychiatry.v32i0.2543
- Donkin A, Rodseth R, Giddy J. A call for SASOP to review their position on the care of ‘transgender and non-binary youth’. S Afr J Psychiatr. 2025;31:a2381. https://doi.org/10.4102/sajpsychiatry.v31i0.2381
- Hall R, Taylor J, Hewitt CE, et al. Impact of social transition in relation to gender for children and adolescents: A systematic review. Arch Dis Child. 2024;109(suppl 2):s12–s18. https://doi.org/10.1136/archdischild-2023-326112
- Ludvigsson JF, Adolfsson J, Hoistad M, Rydelius PA, Kristrom B, Landen M. A systematic review of hormone treatment for children with gender dysphoria and recommendations for research. Acta Paediatr. 2023;112(11):2279–2292. https://doi.org/10.1111/apa.16791
- Thompson L, Sarovic D, Wilson P, Sämfjord A, Gillberg C. A PRISMA systematic review of adolescent gender dysphoria literature: 1) Epidemiology. PLOS Glob Public Health. 2022;2(3):e0000245. https://doi.org/10.1371/journal.pgph.0000245
- Taylor J, Mitchell A, Hall R, et al. Interventions to suppress puberty in adolescents experiencing gender dysphoria or incongruence: A systematic review. Arch Dis Child. 2024;109(suppl 2):s33–s47. https://doi.org/10.1136/archdischild-2023-326669
- Zepf FD, König L, Kaiser A, et al. Beyond NICE: Updated systematic review on the current evidence of using puberty blocking pharmacological agents and cross-sex-hormones in minors with gender dysphoria. Z Kinder Jugendpsychiatr Psychother. 2024;52(3):167–187. https://doi.org/10.1024/1422-4917/a000972
- Miroshnychenko A, Roldan Y, Ibrahim S, et al. Puberty blockers for gender dysphoria in youth: A systematic review and meta-analysis. Arch Dis Child. 2025;110(6):429–436. https://doi.org/10.1136/archdischild-2024-327909
- Miroshnychenko A, Ibrahim S, Roldan Y, et al. Gender affirming hormone therapy for individuals with gender dysphoria aged <26 years: A systematic review and meta-analysis. Arch Dis Child. 2025;110(6):437–445. https://doi.org/10.1136/archdischild-2024-327921
- Cass H. Final report FAQs [homepage on the Internet]. London: The Cass Review; 2024 [cited 2025 Nov 23]. Available from: https://cass.independent-review.uk/home/publications/final-report/final-report-faqs/
- Kulatunga-Moruzi C, Sim P, Mitchell I, et al. The Cass review and gender-related care for young people in Canada: A commentary on the Canadian Paediatric Society position statement on transgender and gender-diverse youth. Arch Sex Behav. 2025;54:3743–3761. https://doi.org/10.1007/s10508-025-03335-8
- Cheung CR, Abbruzzese E, Lockhart E, Maconochie IK, Kingdon CC. Gender medicine and the Cass review: Why medicine and the law make poor bedfellows. Arch Dis Child. 2024;110(5):251–255. https://doi.org/10.1136/archdischild-2024-327994
- Kingdon C, Stingelin-Giles N, Cass H. The Cass review: Distinguishing fact from fiction. Am J Bioeth. 2025;25(6):5–10. https://doi.org/10.1080/15265161.2025.2504397
- McDeavitt K, Cohn J, Levine SB. Critiques of the Cass review: Fact-checking the peer-reviewed and grey literature. J Sex Marital Ther. 2025;51(2):175–199. https://doi.org/10.1080/0092623X.2025.2455133
- Clayton A, Amos AJ, Spencer J, Clarke P. Implications of the Cass review for health policy governing gender medicine for Australian minors. Australas Psychiatry. 2024;33(1):89–95. https://doi.org/10.1177/10398562241276335
- Southern Poverty Law Center. Dynamics within the anti-LGBTQ+ pseudoscience network [homepage on the Internet]. Montgomery, AL: Southern Poverty Law Center; 2023 [cited 2025 Jul 31]. Available from: https://www.splcenter.org/resources/reports/defining-pseudoscience-network/
- Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406. https://doi.org/10.1016/j.jclinepi.2010.07.015
- Chong MC, Sharp MK, Smith SM, et al. Strong recommendations from low certainty evidence: A cross-sectional analysis of a suite of national guidelines. BMC Med Res Methodol. 2023;23(1):68. https://doi.org/10.1186/s12874-023-01895-8
- Kozlowska K, Ambler GR, Dechene S, et al. Evolving national guidelines for the treatment of children and adolescents with gender dysphoria: International perspectives. Hum Syst. 2024;5(2):89–152. https://doi.org/10.1177/26344041241269298
- Brezin F, Busiah K, Leroy C, et al. Endocrine management of transgender adolescents: expert consensus of the French Society of Pediatric Endocrinology and Diabetology Working Group. Arch Pediatr. 2024(8):484–492. https://doi.org/10.1016/j.arcped.2024.07.003
- Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJPP). S2k-Leitlinie Geschlechtsinkongruenz und Geschlechtsdysphorie im Kindes- und Jugendalter: Diagnostik und Behandlung [homepage on the Internet]. AWMF-Registernummer 028-014. 2025 [cited 2025 Nov 23]. Available from: https://register.awmf.org/de/leitlinien/detail/028-014
- Taylor J, Hall R, Heathcote C, Hewitt CE, Langton T, Fraser L. Clinical guidelines for children and adolescents experiencing gender dysphoria or incongruence: A systematic review of recommendations (part 2). Arch Dis Child. 2024;109(suppl 2):s73–s82. https://doi.org/10.1136/archdischild-2023-326500
- Council for Choices in Healthcare in Finland. Medical treatment methods for dysphoria associated with variations in gender identity in minors – Recommendation [homepage on the Internet]. Helsinki: Council for Choices in Healthcare in Finland; 2020 [cited 2025 Nov 25]. Available from: https://palveluvalikoima.fi/en/recommendations#genderidentity
- Swedish National Board of Health and Welfare. Care of children and young people with gender dysphoria – National knowledge support with recommendations for the profession and decision makers [homepage on the Internet]. Stockholm: Swedish National Board of Health and Welfare; 2022 [cited 2025 Nov 25]. Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/kunskapsstod/2022-12-8302.pdf
- NHS England. Children and young people’s gender services: implementing the Cass review recommendations [homepage on the Internet]. London: NHS England; 2024 [cited 2025 Nov 25]. Available from: https://www.england.nhs.uk/long-read/children-and-young-peoples-gender-services-implementing-the-cass-review-recommendations/
- UKOM. Patient safety for children and young people with gender incongruence [homepage on the Internet]. Oslo: Norwegian Healthcare Investigation Board (UKOM); 2023 [cited 2025 Nov 25]. Available from: https://ukom.no/rapporter/pasientsikkerhet-for-barn-og-unge-med-kjonnsinkongruens/sammendrag
- Italian National Bioethics Committee. Risposta al quesito del Ministero della Salute sull’utilizzo della triptorelina nel caso di diagnosi di ‘disforia di genere’ [The use of triptorelin in the treatment of puberty disorders] [homepage on the Internet]. Rome: Italian National Bioethics Committee; 2024 [cited 2025 Nov 25]. Available from: https://bioetica.governo.it/media/ymhlpqt4/abstract-triptorelina.pdf
- Department of Health and Human Services. Treatment for pediatric gender dysphoria: Review of evidence and best practices [homepage on the Internet]. Washington (DC): Department of Health and Human Services (US); 2025 [cited 2025 Nov 25]. Available from: https://opa.hhs.gov/sites/default/files/2025-05/gender-dysphoria-report.pdf
- Ministry of Health. Impact of puberty blockers in gender dysphoric adolescents: An evidence brief [homepage on the Internet]. Wellington: Ministry of Health (NZ); 2024 [cited 2025 Nov 25]. Available from: https://www.health.govt.nz/publications/impact-of-puberty-blockers-in-gender-dysphoric-adolescents-an-evidence-brief
- Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health. 2022;23(suppl 1):S1–S259. https://doi.org/10.1080/26895269.2022.2125695
- Berhanu AE. Understanding the market for gender confirmation surgery in the adult transgender community in the United States: Evolution of treatment, market potential, and unique patient characteristics [homepage on the Internet] [dissertation]. Boston (MA): Harvard Medical School; 2016 [cited 2025 Nov 25]. Available from: https://dash.harvard.edu/server/api/core/bitstreams/db2b5cc5-f52b-4089-8376-a1ec4cafa5db/content
- Steensma TD, Biemond R, De Boer F, Cohen-Kettenis PT. Desisting and persisting gender dysphoria after childhood: A qualitative follow-up study. Clin Child Psychol Psychiatry. 2011;16(4):499–516. https://doi.org/10.1177/1359104510378303
- Cass H. Independent review of gender identity services for children and young people: Final report [homepage on the Internet]. London: The Cass Review; 2024 [cited 2025 Nov 23]. Available from: https://cass.independent-review.uk/wp-content/uploads/2024/04/CassReview_Final.pdf
- Kettula K, Puustinen N, Tynkkynen L, Lempinen L, Tuisku K. Gender dysphoria and detransitioning in adults: An analysis of nine patients from a gender identity clinic in Finland. Arch Sex Behav. 2025;54(5):1981–1990. https://doi.org/10.1007/s10508-025-03176-5
- Littman L, O’Malley S, Kerschner H, Bailey JM. Detransition and desistance among previously trans-identified young adults. Arch Sex Behav. 2024;53(1):57–76. https://doi.org/10.1007/s10508-023-02716-1
|